Skip to main content
Clinical Trials/NCT05525143
NCT05525143
Completed
Not Applicable

Incidence and Risk Factors of Postpartum Hemorrhage at the Brugmann University Hospital in Comparison to the Literature

Brugmann University Hospital1 site in 1 country2,402 target enrollmentOctober 10, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Postpartum Hemorrhage
Sponsor
Brugmann University Hospital
Enrollment
2402
Locations
1
Primary Endpoint
Incidence of PPH
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Postpartum hemorrhage(PPH) is a major cause of maternal morbidity and mortality across the world. Incidence of PPH varies in the literature from 2 to 10%, most recent studies find around 10% of PPH and 2% of severe PPH.

In this study, the incidence of PPH in the maternal ward of the CHU Brugmann will be analyzed. This is a tertiary maternal ward with a high proportion of high risk pregnancies with around 3000 admissions per year.

Primary aim of this study is to evaluate the epidemiology of PPH in the CHU Brugmann, incidence and possible underlying causes will be identified and compared to the current literature. A data mining technique will be used to construct a prediction model for PPH.

Registry
clinicaltrials.gov
Start Date
October 10, 2022
End Date
July 26, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Denis SCHMARTZ

Head of department, anesthesiology

Brugmann University Hospital

Eligibility Criteria

Inclusion Criteria

  • Pregnant women who have given birth vaginally or by cesarean section at the CHU Brugmann between January 1, 2020 and August 31, 2022
  • ≥ 18 years

Exclusion Criteria

  • Age ≤ 18 years
  • Age \> 60 years
  • delivery before 25th week of pregnancy
  • delivery outside of the hospital

Outcomes

Primary Outcomes

Incidence of PPH

Time Frame: 48 hours

Descriptive statistics of incidence (%) of PPH occuring during the first 48h after delivery.

Study Sites (1)

Loading locations...

Similar Trials